Demant A/s · OMXCOP:DEMANT
Demant A/s — Investor Day (2016)
27 slides from Demant A/s's investor day presentation, Sep 28, 2016
Slide 1: Hearing Implants
Hearing Implants Jes Olsen President, Hearing Implants
Slide 2: Jes Olsen, President, Hearing Implants
Jes Olsen President, Hearing Implants Curriculum • Born 1960 • B.Sc. in electronic engineering and electroacoustics • Employed with the William Demant Group since 1986 • General Manager, Oticon AB, Stockholm 1993-1996 • Various senior management roles in Oticon, including Vice President of R&D, 1997
Slide 3: Agenda
Agenda • Hearing implant market • Our hearing implant journey • Our strategic ambition • Technology, innovation and products • Roadmap principles • Global distribution • Q&A 3
Slide 4: Hearing implant market
Hearing implant market Strong fundamental growth drivers 4
Slide 5: Cochlear implant (CI) market
Cochlear implant (CI) market *Oticon Other (EUR million) 2009-15 CAGR 10% Medical 1300 1100 900 700 AB 2.5% of all aged 75+ have a 130K+ potential new CI 500 hearing loss that qualifies candidates per year with MEDEL them as CI candidates severe/profound hearing loss Cochlear Growth Pediatric Adult
Slide 6: Bone-anchored hearing systems (BAHS) market
Bone-anchored hearing systems (BAHS) market (EUR million) 2009-15 CAGR 14% Other 150 MEDEL 100 50 Oticon Medical ~5% 0 Penetration rate and only 150K+ users across the world approx. 25K implantations and fastest growing hearing Cochlear per year implant segment Transcutan Growth active drivers Trans
Slide 7: William Demant Hearing Implants: Journey and strategic ambition
William Demant Hearing Implants Journey and strategic ambition 7
Slide 8: William Demant's hearing implant journey
William Demant’s hearing implant journey Bone-anchored hearing systems (BAHS) Today Minimally Invasive Ponto Surgery 2007 2009 2011 2012 (MIPS) Oticon Medical established in Launch of the Ponto System, Ponto Pro Power Wide Ponto Implant 2013 2014 – a truly new perspective on Gothenburg, Sweden bring
Slide 9: Our strong position
Our strong position Long-term ambition of becoming a leading hearing implant company William Demant Group synergies Strong know-how to create new growth • The power house of hearing • Century-long history in sound processing • Research capabilities and audiology • Three decades of cochlear implant •
Slide 10: William Demant's Hearing Implant organisation
William Demant’s Hearing Implant organisation Strong and complementary local competencies • Neuro stimulation and CI audiology Nice • Hearing implant technology Gothenburg • Class 3 manufacturing and OC Copenhagen • Audiology and signal processing Copenhagen • Design of externals and micro mechanics
Slide 11: Technology and innovation
Technology and innovation Product update and roadmap principles 11
Slide 12: CI Neuro update
CI Neuro update Designed for a future of sound • 130+ patients in more than 10 countries • Excellent feedback from surgeons • Good audiological outcomes – even though it is still early days • No implant failures after implantation • No hardware design errors detected in neither implant nor BTE • New
Slide 13: CI Neuro Zti: The receiver
CI Neuro Zti The receiver • Overall Impression • Ergonomics: 9.0/10 • Ease of use: 9.0/10 • Compactness: 9.0/10 • Profile/Height: 8.9/10 • General design highly appreciated • Everybody really appreciated • The compactness of the device (small surgical footprint and low height) • The general ergonomi
Slide 14: CI Neuro Zti: Fixation screws
CI Neuro Zti Fixation screws • Evaluation details • Stabilisation of the receiver on the skull: 8.9/10 • Ease of use: 10/10 • Efficiency: 9.3/10 • Surgeons very much appreciated the screw fixation system • Rated as being easy to use, very convenient, easily and efficiently stabilising the receiver o
Slide 15: CI Neuro Zti: The EVO electrode array
CI Neuro Zti The EVO electrode array • Overall impression • Lead: 7.9/10 • Ease of insertion: 6.9/10 • Softness: 7.2/10 • All surgeries were performed with the EVO electrode, and it is generally very well perceived • The "lead" being rated as very good • The softness of atraumatic arrays can sometim
Slide 16: CI end-user stories
CI end-user stories ”I’m able to answer my grandchildren’s many questions and can keep up with their conversations, even though they tend to go off in all directions.” Neuro CI user after activation and first experiences - Karin Christiansen, Neuro CI, left “One month after it was fitted, my boyfrie
Slide 17: CI roadmap principles
CI roadmap principles More competitive, step-by-step Step #1 Getting the most important right • A competitive, fully modern implant, Neuro Zti • Competitive and innovative signal processing based on Oticon technology for highest possible outcomes, Neuro One Step #2 Getting the important details righ
Slide 18: Neuro 2 – the best sound ever designed
Neuro 2 – the best sound ever designed USB powered IP 58 18
Slide 19: For all ages and situations
For all ages and situations Clip Swim kit IP 68 Ear plug retention kit Safety line 19
Slide 20: The first Genie Oticon Medical CI
The first Genie Oticon Medical CI 20
Slide 21: BAHS status
BAHS status Constant improvements of what is already good • MIPS • A truly new perspective on tissue preservation • Has the potential to become the future industry standard surgical method • Ponto BHX implant • Is replacing our classic hearing implant faster than expected • Fuels growth because of h
Slide 22: BAHS roadmap principles
BAHS roadmap principles Three choices for optimum outcome Percutaneous Direct transmission 1 • Most power and largest flexibility • Well proven technology with known limitations • Currently the golden standard of care Active transcutaneous direct transmission • Best cosmetics and higher patient acce
Slide 23: Ponto 3 Super Power
Ponto 3 Super Power Free focus Inium Sense feedback shiled Bineaural processing Super Power made beautiful • The world’s first abutment level Super Power Maximum Output Force level at 90 dB SPL input sound processor • Fitting range down to 65 dB HL (BC) • Increased MFO across the entire bandwidth •
Slide 24: The bone conduction hearing implant
The bone conduction hearing implant The solution for continuous strong growth of the BAHS Market • No need for the penetrating abutment – maintains the Ponto sound quality • Will open up the market for bone conduction solutions • More invasive surgery • Training and support • Higher price 24
Slide 25: Global distribution
Global distribution The core of managing a successful hearing implant business 25
Slide 26: Aiming for global presence
Aiming for global presence • Only limited global footprint with no access to US and China and just recently approved in several key European markets • Wholesale • All William Demant sales companies and most William Demant distributors will become distributors for Oticon Medical • Dedicated experts a
Slide 27: Thank you
William Demant / Thank you